Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-22-017343

Head of R&D, CSO gave up 1,216 shares (to pay taxes)

  • Head of R&D, CSO acquired 8,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rodino-Klapac Louise · Head of R&D, CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-04 Shares withheld for taxes : show line 1 in the form −1,216 $79.20 $96,307 64,111 D
2022-03-07 Grant or award : show line 2 in the form +8,000 72,111 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-07 Grant or award : show line 3 in the form Stock Option (right to buy) +48,000 48,000 D
Loading xslF345X03/doc4.xml…